AI
COLL icon

AXS Investments’s Collegium Pharmaceutical COLL Stock Holding History

AXS Investments’s Portfolio COLL Stock Details COLL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q2 		– Sell
-5,445
Closed -$211K – 237
2024
Q1 		$211K Buy
+5,445
New +$191K 0.05% 279
2023
Q1 		– Sell
-4,157
Closed -$96.4K – 383
2022
Q4 		$96.4K Buy
+4,157
New +$83.8K 0.03% 236

Other funds holding COLL

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Pacer Advisors
Pacer Advisors Malvern, Pennsylvania $35.6B AUM 18.19% 1-Year Est. Return
EAM
Eventide Asset Management Boston, Massachusetts $6.05B AUM 76.64% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
RCMNY
Rubric Capital Management (New York) New York $9.44B AUM 68.42% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
Principal Financial Group
Principal Financial Group Des Moines, Iowa $187B AUM 18.48% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Fuller & Thaler Asset Management
Fuller & Thaler Asset Management San Mateo, California $29.7B AUM 43.33% 1-Year Est. Return

AXS Investments's COLL Position: Q2 2024 in Review

AXS Investments sold out of Collegium Pharmaceutical (COLL) in Q2 2024, closing a stake of 5,445 shares — an estimated $211K sold.

AXS Investments first reported a position in COLL in Q4 2022 and held it in 2 quarters. The position peaked at $211K in Q1 2024. 229 funds tracked by Wall St. Rank hold COLL as of Q2 2024.

  • AXS Investments reported no remaining Collegium Pharmaceutical position as of Q2 2024 after selling out during the quarter.
  • AXS Investments sold 5,445 Collegium Pharmaceutical shares in Q2 2024, an estimated $211K.
  • AXS Investments first reported a position in Collegium Pharmaceutical in Q4 2022 and held it in 2 quarters.
  • AXS Investments's Collegium Pharmaceutical position peaked at $211K in Q1 2024.
  • 229 funds tracked by Wall St. Rank held Collegium Pharmaceutical as of Q2 2024.

Based on AXS Investments's 13F filing for Q2 2024, filed 13 Aug 2024.